SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID‐19: The International Study of Inflammation in COVID‐19

Severe coronavirus disease 2019 (COVID‐19) is a hyperinflammatory syndrome. The biomarkers of inflammation best suited to triage patients with COVID‐19 are unknown. We conducted a prospective multicenter observational study of adult patients hospitalized specifically for COVID‐19 from February 1, 20...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medical virology 2024-01, Vol.96 (1), p.e29389-n/a
Hauptverfasser:	Vasbinder, Alexi, Padalia, Kishan, Pizzo, Ian, Machado, Kristen, Catalan, Tonimarie, Presswalla, Feriel, Anderson, Elizabeth, Ismail, Anis, Hutten, Christina, Huang, Yiyuan, Blakely, Pennelope, Azam, Tariq U., Berlin, Hanna, Feroze, Rafey, Launius, Christopher, Meloche, Chelsea, Michaud, Erinleigh, O'Hayer, Patrick, Pan, Michael, Shadid, Husam R., Rasmussen, Line Jee Hartmann, Roberts, Donald A., Zhao, Lili, Banerjee, Mousumi, Murthy, Venkatesh, Loosen, Sven H., Chalkias, Athanasios, Tacke, Frank, Reiser, Jochen, Giamarellos‐Bourboulis, Evangelos J., Eugen‐Olsen, Jesper, Pop‐Busui, Rodica, Hayek, Salim S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biomarkers Coronaviruses COVID-19 COVID-19 - diagnosis CRP C‐reactive protein Dimers Ferritin Ferritins Humans infection Inflammation Inflammation - diagnosis Interleukin 6 International studies Mechanical ventilation Observational studies Procalcitonin Prognosis Prospective Studies Receptors, Urokinase Plasminogen Activator risk prediction SARS‐CoV‐2 Sensitivity soluble urokinase plasminogen activator receptor SuPAR triage U-Plasminogen activator Urokinase Ventilation Viral diseases Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!